Financial reports
10-Q
2024 Q2
Quarterly report
16 Jan 24
10-Q
2024 Q1
Quarterly report
12 Oct 23
10-K
2023 FY
Annual report
25 Aug 23
10-Q
2023 Q3
Quarterly report
14 Apr 23
10-Q
2023 Q2
Quarterly report
13 Jan 23
10-Q
2023 Q1
Quarterly report
13 Oct 22
10-K
2022 FY
Annual report
29 Aug 22
10-Q
2022 Q3
Quarterly report
14 Apr 22
10-Q
2022 Q2
Quarterly report
12 Jan 22
10-Q
2022 Q1
Quarterly report
14 Oct 21
Current reports
8-K
Submission of Matters to a Vote of Security Holders
11 Dec 23
8-K
Regulation FD Disclosure
19 Sep 23
8-K
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
28 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Jul 23
8-K
Regulation FD Disclosure
25 Apr 23
8-K
Biomerica Announces Proposed Underwritten
7 Mar 23
8-K
Departure of Directors or Certain Officers
2 Mar 23
8-K
Regulation FD Disclosure
7 Feb 23
8-K/A
Submission of Matters to a Vote of Security Holders
29 Dec 22
8-K
Departure of Directors or Certain Officers
16 Dec 22
Registration and prospectus
S-3
Shelf registration
27 Sep 23
424B5
Prospectus supplement for primary offering
6 Mar 23
424B5
Prospectus supplement for primary offering
2 Mar 23
424B5
Prospectus supplement for primary offering
2 Mar 23
S-8
Registration of securities for employees
21 May 21
424B5
Prospectus supplement for primary offering
22 Jan 21
S-3/A
Shelf registration (amended)
11 Sep 20
S-3
Shelf registration
21 Jul 20
424B5
Prospectus supplement for primary offering
20 Mar 20
D
$2M in equity, sold $2M, 1 investor
27 Feb 20
Proxies
DEF 14A
Definitive proxy
27 Sep 23
DEF 14A
Definitive proxy
27 Sep 22
DEF 14A
Definitive proxy
28 Sep 21
DEF 14A
Definitive proxy
25 Sep 20
DEF 14A
Definitive proxy
24 Sep 19
DEF 14A
Definitive proxy
28 Sep 18
DEF 14A
Definitive proxy
28 Sep 17
DEF 14A
Definitive proxy
28 Sep 16
DEF 14A
Definitive proxy
28 Sep 15
DEF 14A
Definitive proxy
29 Sep 14
Other
EFFECT
Notice of effectiveness
2 Oct 23
CORRESP
Correspondence with SEC
29 Sep 23
UPLOAD
Letter from SEC
29 Sep 23
EFFECT
Notice of effectiveness
1 Oct 20
CORRESP
Correspondence with SEC
28 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
CORRESP
Correspondence with SEC
9 Sep 20
UPLOAD
Letter from SEC
28 Jul 20
EFFECT
Notice of effectiveness
20 Jul 17
CORRESP
Correspondence with SEC
18 Jul 17
Ownership
SC 13G/A
Granahan Investment Management, LLC
14 Feb 24
SC 13G
WASATCH ADVISORS LP
9 Feb 24
4
Catherine Coste
14 Dec 23
4
John P. Kenny
14 Dec 23
4
DAVID MOATAZEDI
14 Dec 23
4
Jane Emerson
14 Dec 23
4
Gary Lu
14 Dec 23
4
ALLEN BARBIERI
14 Dec 23
4
Zackary S. Irani
14 Dec 23
4
DAVID MOATAZEDI
11 Dec 23